Table 4.
Anthropometric and body composition parameters at baseline and after HBD nutritional intervention according to genotypes 1
| Parameters | Baseline | Week 12 | ||||
|---|---|---|---|---|---|---|
| Total (n = 44) | T (−) (n = 20) | T (+) (n = 24) | Total (n = 44) | T (−) (n = 20) | T (+) (n = 24) | |
| Weight (Kg) | 97.79 ± 15.46 | 89.60 ± 14.43 | 103.93 ± 13.69d | 88.17 ± 16.01a | 80.51 ± 15.00b | 93.92 ± 14.78c |
| BMI (Kg/m 2 ) | 40.72 ± 5.89 | 38.58 ± 7.23 | 42.32 ± 4.31 | 36.69 ± 6.05a | 34.68 ± 7.38 | 38.20 ± 4.61c |
| Abdomen (cm) | 124.43 ± 12.18 | 120.06 ± 12.76 | 127.71 ± 11.12 | 116.36 ± 12.59a | 111.83 ± 12.54b | 119.75 ± 12.02c |
| Hip (cm) | 124.24 ± 10.94 | 119.22 ± 12.58 | 128.00 ± 8.17 | 116.55 ± 10.82 | 111.56 ± 12.09 | 120.29 ± 8.42c |
| Neck (cm) | 41.93 ± 3.09 | 39.90 ± 2.88 | 42.74 ± 2.91 | 39.23 ± 2.90a | 37.88 ± 2.36b | 40.51 ± 2.98c |
| TBFat (Kg) | 46.91 ± 8.88 | 41.03 ± 7.18 | 51.51 ± 7.57d | 40.42 ± 9.36 | 35.21 ± 7.79b | 45.29 ± 8.78c,e |
| TBLean (Kg) | 47.67 ± 8.09 | 44.86 ± 6.96 | 50.17 ± 8.95 | 44.69 ± 7.26a | 42.84 ± 6.61 | 46.33 ± 8.13c |
| PBF (%) | 48.24 ± 3.52 | 46.50 ± 2.90 | 49.46 ± 3.56 | 45.87 ± 3.83a | 43.57 ± 3.79 | 48.01 ± 2.78 |
| BMD total body (g/cm2) | 1.21 ± 0.12 | 1.15 ± 0.11 | 1.27 ± 0.11 | 1.19 ± 0.12a | 1.14 ± 0.11 | 1.24 ± 0.11c, e |
| BMC total body (g) | 2460.65 ± 351.30 | 2270.67 ± 255.15 | 2645.50 ± 355.62 | 2507.50 ± 408.15a | 2270.67 ± 255.15 | 2750.60 ± 356.15c |
| RMR (Kcal/die) | 1762.47 ± 299.00 | 1658.68 ± 257.43 | 1855.02 ± 330.95 | 1652.30 ± 268.55 | 1658.68 ± 257.43 | 1713.15 ± 300.66c |
1All values are mean ± SD. BMI: Body Mass Index, TBFat: Total Body Fat; TBLean: Total Body Lean; PBF: Percentage of Total Body Fat; BMD: Bone Mineral Density; BMC:Bone Mineral Content; RMR: Resting Metabolic Rate.
aReflects the significance of the differences between total population at baseline vs total population at week 12 determined with an independent t test (p ≤ 0.05).
bReflects the significance of the differences between T(−) carrier at baseline vs T(−) carrier at week 12 determined with an independent t test (p ≤ 0.05).
cReflects the significance of the differences between T(+) carrier at baseline vs T(+) carrier at week 12 determined with an independent t test (p ≤ 0.05).
dReflects the significance of the differences between T(−) carrier at baseline vs T(+) carrier at baseline determined with an independent t test (p ≤ 0.05).
eReflects the significance of the differences between T(−) carrier at week 12 vs T(+) carrier at week 12 determined with an independent t test (p ≤ 0.05).